Within the past 3 months, the treatment landscapes for ovarian and cervical cancer have been evolving, with multiple updates to procedures, practices, and guidelines.


By Megan Brooks

NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to advise against ovarian cancer screening in asymptomatic women at average risk, saying the potential harms of screening outweigh the benefits.

Read More

Research in Review

A study out of the United Kingdom has identified a key gene signature in ovarian cancer that may be useful in predicting survival.

Read More

A look at more than 10 years of data has shown that many patients with ovarian cancer covered by Medicare are not receiving treatment consistent with National Comprehensive Cancer Network (NCCN) recommendations, despite these having been shown to improve outcomes without increasing costs. 

Read More

Subscribe to Ovarian Cancer